Zura Bio (ZURA) Assets Average (2022 - 2026)
Zura Bio (ZURA) posted quarterly Assets Average of $171.3 million for Q1 2026, down 2.68% year-over-year from $176.0 million in Q1 2025, and up 32.85% quarter-over-quarter from $128.9 million in Q4 2025.
Zura Bio (ZURA) Assets Average (2022 - 2026) Analysis & Trends
Zura Bio's Assets Average history runs 5 years deep, the most recent figure standing at $171.3 million for Q1 2026.
- In Q1 2026, Assets Average fell 2.68% year-over-year to $171.3 million; the TTM figure through Mar 2026 stood at $171.3 million (down 2.68% YoY), while the FY2025 annual figure was $146.7 million, up 4.67% from the prior year.
- Assets Average for Q1 2026 stood at $171.3 million, up from $128.9 million in the prior quarter.
- The five-year high for Assets Average was $189.3 million in Q3 2024, with the low at $24.8 million in Q1 2023.
- The 5-year median for Assets Average is $140.1 million (2022), against an average of $130.0 million.
- The sharpest annual moves came in 2023 and 2024: Assets Average tumbled 82.32% in 2023, then jumped 285.37% in 2024.
- Zura Bio's Assets Average stood at $72.9 million in 2022, then soared by 40.96% to $102.7 million in 2023, then soared by 79.43% to $184.3 million in 2024, then tumbled by 30.04% to $128.9 million in 2025, then jumped by 32.85% to $171.3 million in 2026.
- Business Quant data shows ZURA's Assets Average at $171.3 million in Q1 2026, $128.9 million in Q4 2025, and $150.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Zura Bio | 706.30 Mn | 706.30 Mn | - | 221.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 221.02 Mn |
| Mar 31, 2026 | 171.29 Mn |
| Dec 31, 2025 | 128.94 Mn |
| Sep 30, 2025 | 150.87 Mn |
| Jun 30, 2025 | 165.15 Mn |
| Mar 31, 2025 | 176.01 Mn |
| Dec 31, 2024 | 184.30 Mn |
| Sep 30, 2024 | 189.29 Mn |
| Jun 30, 2024 | 139.99 Mn |
| Mar 31, 2024 | 95.66 Mn |
| Dec 31, 2023 | 102.72 Mn |
| Sep 30, 2023 | 108.96 Mn |
| Jun 30, 2023 | 78.86 Mn |
| Mar 31, 2023 | 24.82 Mn |
| Dec 31, 2022 | 72.87 Mn |
| Sep 30, 2022 | 140.26 Mn |
| Jun 30, 2022 | 140.14 Mn |
| Mar 31, 2022 | 140.40 Mn |